TY - JOUR
T1 - Leucine augments specific skeletal muscle mitochondrial respiratory pathways during recovery following 7 days of physical inactivity in older adults
AU - Arentson-Lantz, Emily J.
AU - Mikovic, Jasmine
AU - Bhattarai, Nisha
AU - Fry, Christopher S.
AU - Lamon, Severine
AU - Porter, Craig
AU - Paddon-Jones1, Douglas
N1 - Publisher Copyright:
Copyright © 2021 the American Physiological Society.
PY - 2021/5
Y1 - 2021/5
N2 - Leucine supplementation attenuates the loss of skeletal muscle mass and function in older adults during bed rest. We sought to determine whether leucine could also preserve and/or restore mitochondrial function and muscle oxidative capacity during periods of disuse and rehabilitation. Healthy, older adults (69.1 ± 1.1 yr) consumed a structured diet with supplemental leucine (LEU: 0.06 g/kg body weight/meal; n = 8) or alanine (CON: 0.06 g/kg body weight/meal; n = 8) during 7 days of bed rest and 5 days of inpatient rehabilitation. A 75-g oral glucose tolerance test (OGTT) was performed at baseline (PreBR), after bed rest (PostBR), and rehabilitation (PostRehab) and used to calculate an indicator of insulin sensitivity and metabolic clearance rate (MCR). Tissue samples from the m. vastus lateralis were collected at PreBR, PostBR, and PostRehab to assess mitochondrial respiratory capacity and protein markers of the oxidative phosphorylation and a marker of the antioxidant defense systems. During bed rest, leucine tended to preserve insulin sensitivity (change in MCR, CON vs. LEU:-3.5 ± 0.82 vs. LEU: 0.98 ± 0.88, P = 0.054), but had no effect on mitochondrial respiratory capacity (change in state 3þsuccinate CON vs. LEU 8.7 ± 6.1 vs. 7.3 ± 4.1 pmol O2/s/mg tissue, P = 0.10). Following rehabilitation, leucine increased ATP-linked respiration (CON vs. LEU:-8.9 ± 6.2 vs. 15.5 ± 4.4 pmol O2/s/mg tissue, P = 0.0042). Although the expression of mitochondrial respiratory and antioxidant proteins was not impacted, leucine supplementation preserved specific pathways of mitochondrial respiration, insulin sensitivity, and a marker of oxidative stress during bed rest and rehabilitation.
AB - Leucine supplementation attenuates the loss of skeletal muscle mass and function in older adults during bed rest. We sought to determine whether leucine could also preserve and/or restore mitochondrial function and muscle oxidative capacity during periods of disuse and rehabilitation. Healthy, older adults (69.1 ± 1.1 yr) consumed a structured diet with supplemental leucine (LEU: 0.06 g/kg body weight/meal; n = 8) or alanine (CON: 0.06 g/kg body weight/meal; n = 8) during 7 days of bed rest and 5 days of inpatient rehabilitation. A 75-g oral glucose tolerance test (OGTT) was performed at baseline (PreBR), after bed rest (PostBR), and rehabilitation (PostRehab) and used to calculate an indicator of insulin sensitivity and metabolic clearance rate (MCR). Tissue samples from the m. vastus lateralis were collected at PreBR, PostBR, and PostRehab to assess mitochondrial respiratory capacity and protein markers of the oxidative phosphorylation and a marker of the antioxidant defense systems. During bed rest, leucine tended to preserve insulin sensitivity (change in MCR, CON vs. LEU:-3.5 ± 0.82 vs. LEU: 0.98 ± 0.88, P = 0.054), but had no effect on mitochondrial respiratory capacity (change in state 3þsuccinate CON vs. LEU 8.7 ± 6.1 vs. 7.3 ± 4.1 pmol O2/s/mg tissue, P = 0.10). Following rehabilitation, leucine increased ATP-linked respiration (CON vs. LEU:-8.9 ± 6.2 vs. 15.5 ± 4.4 pmol O2/s/mg tissue, P = 0.0042). Although the expression of mitochondrial respiratory and antioxidant proteins was not impacted, leucine supplementation preserved specific pathways of mitochondrial respiration, insulin sensitivity, and a marker of oxidative stress during bed rest and rehabilitation.
KW - Aging
KW - Bed rest
KW - Dietary supplementation
KW - Nutrition
UR - http://www.scopus.com/inward/record.url?scp=85106540272&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106540272&partnerID=8YFLogxK
U2 - 10.1152/japplphysiol.00810.2020
DO - 10.1152/japplphysiol.00810.2020
M3 - Article
C2 - 33764170
AN - SCOPUS:85106540272
SN - 8750-7587
VL - 130
SP - 1522
EP - 1533
JO - Journal of Applied Physiology
JF - Journal of Applied Physiology
IS - 5
ER -